Yasmin M Abaza

23PUBLICATIONS
149CO-AUTHORS
Gene and molecular therapyHaematological tumoursTransplantation immunologyMedical infection agents (incl. prions)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Jul 02, 2026
Risk Prognostication After Hypomethylating Agents Combined With Venetoclax in AML: The PRISM Risk Model.

|Jun 29, 2026
Outcomes of patients with higher-risk myelodysplastic syndromes/neoplasms treated with hypomethylating agents + venetoclax-an analysis from the International Consortium for MDS (icMDS) VALIDATE database.

|Apr 15, 2026
PTP4A2 promotes leukemogenesis through inhibiting the p53 tumor suppressor signaling pathway in leukemia-initiating cells.

|Dec 23, 2025
Donor-derived acute myeloid leukemia after solid organ transplant: evidence for leukemic stem cell transmission.

Alok Swaroop, Timothy Oh, Kristy Wolniak

|Dec 06, 2025
Outcomes of relapsed or refractory acute myeloid leukemia after menin inhibition failure.

Kuo-Kai Chin, Brian J Ball, Yasmin Abaza

|Nov 25, 2025
Optimizing lower intensity triplet therapy in acute myeloid leukemia: a practical guide.

Wei-Ying Jen, Curtis A Lachowiez, Jennifer Marvin-Peek

Pageof 4

Frequent Collaborators

8 joint publications

Anand Patel

8 joint publications

Talha Badar

5 joint publications

Vamsi Kota

5 joint publications

Tapan M Kadia